Voxel S.A. (WSE:VOX)

Revenue by Segment

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Diagnostics - Medical Services and Sales of Radiopharmaceuticals		386.77M	331.98M	252.78M	196.21M	149.25M
Diagnostics - Medical Services and Sales of Radiopharmaceuticals Growth		16.50%	31.33%	28.83%	31.47%	10.52%
Therapy - Neuroradiosurgery		13.83M	11.92M	10.06M	9.10M	7.75M
Therapy - Neuroradiosurgery Growth		16.09%	18.45%	10.54%	17.50%	-9.03%
IT & Infrastructure - IT Products and Laboratory Equipment		128.39M	101.55M	137.97M	170.91M	156.96M
IT & Infrastructure - IT Products and Laboratory Equipment Growth		26.42%	-26.40%	-19.27%	8.89%	151.35%
Exclusions/Unassigned		-21.22M	-21.27M	-40.17M	-84.33M	-65.08M
Therapy - Hospitality		-	-	-	150.77M	78.78M
Therapy - Hospitality Growth		-	-	-	91.39%	272.00%
Total		507.77M	424.18M	360.64M	442.66M	327.64M
Total Growth		19.71%	17.62%	-18.53%	35.11%	54.80%

Revenue by Geography

Financials in millions PLN. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Poland		496.62M	412.06M	405.62M	434.42M	322.66M
Poland Growth		20.52%	1.59%	-6.63%	34.64%	54.34%
Abroad		11.16M	12.12M	9.18M	8.25M	4.99M
Abroad Growth		-7.95%	32.04%	11.34%	65.38%	90.96%
Total		507.77M	424.18M	414.80M	442.66M	327.64M
Total Growth		19.71%	2.26%	-6.29%	35.11%	54.80%

Source: S&P Global Market Intelligence.